More randomization in phase II trials: necessary but not sufficient

J Natl Cancer Inst. 2011 Jul 20;103(14):1075-7. doi: 10.1093/jnci/djr238. Epub 2011 Jun 27.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Clinical Trials, Phase II as Topic* / methods
  • Clinical Trials, Phase II as Topic* / standards
  • Clinical Trials, Phase III as Topic
  • Confounding Factors, Epidemiologic
  • Endpoint Determination*
  • Evidence-Based Medicine
  • Humans
  • Molecular Targeted Therapy* / methods
  • Molecular Targeted Therapy* / standards
  • Molecular Targeted Therapy* / trends
  • Patient Selection
  • Randomized Controlled Trials as Topic* / methods
  • Randomized Controlled Trials as Topic* / statistics & numerical data
  • Research Design* / standards

Substances

  • Antineoplastic Agents